Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results […]
Study finds HIV+ cancer patients benefit from immunotherapy
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi […]
Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy
A large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has found that the mutational […]
Obesity both feeds tumors and helps immunotherapy kill cancer
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against […]